Get started
Author

Jason Saenz

OpenAlex ID: A5113712861
Abstract 5042: Urine as a non-invasive proxy for plasma in prostate cancer-related liquid biopsy applications
2024 · Nafiseh Jafari, Jason Saenz, et al. · Cancer Research · 2
79. Extraction of multiple analytes in liquid biopsy may improve the diagnosis of breast cancer
2023 · Nafiseh Jafari, Mayer Saidian, et al. · Cancer Genetics · 1
Abstract A083: Automated Processing of Up to 50 mL Urine Enhances Recovery of Low-Abundance KRAS G12V ctDNA for Early Detection of Pancreatic Cancer
2026 · Nafiseh Jafari, Jason Saenz, et al. · Cancer Research
Abstract 5328: Analytical performance of magnetic bead-based cfDNA extraction with a low input targeted DNA enrichment.
2026 · Mayer Saidian, Yingmin Wang, et al. · Cancer Research
Abstract 7835: Integrated DNA/RNA recovery from 1-20 mL inputs enables sensitive KRAS G12V detection in a liquid biopsy model.
2026 · Mayer Saidian, Jason Saenz, et al. · Cancer Research
Abstract 6336: AmbientcfRNApreservation: standardized extraction reveals superior stability in a multi-analyte tube
2026 · Emily Medina, Tony Baker, et al. · Cancer Research
Abstract 7837: Enhanced sensitivity and scalability in liquid biopsy through integrated high-volume cfDNA extraction and droplet digital PCR mutation detection.
2026 · Nafiseh Jafari, Andrew Partner, et al. · Cancer Research
Abstract 7836: Automated high-volume cfDNA extraction on a liquid-handling platform achieves analytical equivalence to a manual high-input magnetic-bead workflow with 96-sample throughput.
2026 · Nafiseh Jafari, Cameron Van Dieren, et al. · Cancer Research
Abstract A052: Efficient recovery of cell-free DNA from synthetic cerebrospinal fluid enables sensitive molecular profiling in brain cancer
2026 · Nafiseh Jafari, Jason Saenz, et al. · Cancer Research
Abstract B039: Urine liquid biopsy for kidney cancer: High-volume cfRNA extraction enhances detection of renal cancer biomarkers for early detection
2026 · Nafiseh Jafari, Jason Saenz, et al. · Cancer Research
Abstract PS2-12-13: Breast Cancer Mutation Detection via Liquid Biopsy Using cfDNA from 50 mL Urine Samples
2026 · N. Jafari, Mayer Saidian, et al. · Clinical Cancer Research
Abstract A030: Detection of Clinically Actionable RNA Fusions Across Multiple Cancer Types Using Optimized cfRNA Extraction from Diverse Sample Matrices
2026 · Nafiseh Jafari, Yabin Lu, et al. · Cancer Research
High-Volume cfDNA Extraction Enables Rare Variant Recovery in Liquid Biopsy for Early Cancer Detection
2025 · Nafiseh Jafari, Jason Saenz, et al. · The Journal of Liquid Biopsy
PDF
Abstract 4571: Ultra sensitive detection and quantification of low frequency variants in plasma using nRichDX extraction and PacBio SBB sequencing
2025 · Mayer Saidian, Alex Sockell, et al. · Cancer Research
Abstract A020: Enhanced cell-free RNA (cfRNA) recovery for liquid biopsy applications: Comparative analysis using controlled RNA samples for early and advanced cancer detection
2024 · Nafiseh Jafari, Mayer Saidian, et al. · Clinical Cancer Research
Enhancing sensitivity of CTDNA copy number detection by increasing plasma sample volume
2024 · Nafiseh Jafari, Jason Saenz, et al. · The Journal of Liquid Biopsy
PDF
Abstract A005: Exploring liquid biopsy for the detection of bladder cancer: Unraveling RNA fusions
2024 · Mayer Saidian, Jason Saenz, et al. · Clinical Cancer Research
Abstract 2430: Enhancing urine-based cfDNA detection for prostate cancer diagnosis through increased urine input volume
2024 · Nafiseh Jafari, Annika Dorn, et al. · Cancer Research
Abstract 5043: Achieving sensitivity of 0.1% variant allele frequency (VAF) in plasma and urine with the nRichDX revolution sample prep system evaluated on the the MassARRAY system
2024 · Nafiseh Jafari, Mayer Saidian, et al. · Cancer Research
Works count: 19
Citation count: 3
H-index: 1
I10-index:
Year
Topic
Type